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Abstract 
Skeletal muscle possesses a remarkable plasticity and responds to environmental and 
physiological challenges by changing its phenotype in terms of size, composition,and 
metabolic properties. Muscle fibers rapidly adapt to drastic changes in energy demands during 
exercise through fine-tuning of the balance between catabolic and anabolic processes. One 
major sensor of energy demand in exercising muscle is AMP-activated protein kinase 
(AMPK). Recent advances have shed new light on the relevance of AMPKboth as a multi-
task gatekeeper and as an energy regulator in skeletal muscle. Here, we summarize recent 
findings on the function of AMPK in skeletal muscle adaptations to contraction 
andhighlightits role in the regulation of energy metabolism and the control of skeletal muscle 
regeneration post-injury. 
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Glossary 
Acetyl-coenzyme A (CoA) carboxylase (ACC): an enzyme that catalyzes the carboxylation 
of acetyl-CoA to malonyl-CoA, a metabolic intermediate that inhibits fatty acid uptake into 
mitochondria. ACC exists as two isoforms, ACC1 and ACC2. ACC1 is highly expressed in 
liver, and brown and white adipose and ACC2 is principally expressed in skeletal and cardiac 
muscles. ACC phosphorylation by AMPK leads to inhibition of its activity. 
AMP-activated protein kinase (AMPK): a serine/threonine protein kinase and sensor of 
cellular energy and nutrient status in eukaryotic cells.  
Ca
2+
/calmodulin-dependent protein kinase kinase  (CaMKK): a serine/threonine 
protein kinase that phosphorylates and activates AMPK when intracellular Ca
2+
 is increased. 
Endurance exercise training: generally encompasses exercise durations of several minutes 
up to several hours at various exercise intensities, incorporating repetitive exercise such as 
cycling, running, or swimming. 
Glucose transporter type 4 (GLUT4): an insulin-regulated glucose transporter primarily 
found in adipocytes,and cardiac and skeletal muscles. In skeletal muscle, insulin, contraction 
,or AMPK activation induce the translocation of GLUT4 from intracellular vesicles to the 
plasma membrane for the delivery of glucose into the muscle cell. 
Liver kinase B1 (LKB1): a serine/threonine protein kinase upstream of AMPK and other 
AMPK-relatedkinases. LKB1 activity does not change under conditions of metabolic stress 
such as during skeletal muscle contraction. 
M1 pro-inflammatory macrophages: macrophages associated with acute inflammation that 
express specific pro-inflammatory cytokines such astumornecrosis factor  (TNF-) or IL-
1 
M2 anti-inflammatory macrophages: macrophages associated with healing that express 
specific anti-inflammatory cytokines such as transforming growthfactor  (TGF-) or IL-10. 
 4 
Mechanistictarget of rapamycin complex (mTORC): composed of two distinct complexes 
mTORC1 and mTORC2, that are involved in protein synthesis, metabolism, proliferation, 
growth and survival. The mTORC and AMPK signaling pathways are opposite in their 
function. 
Muscle glucose uptake: the mechanism by which glucose is transported from the plasma into 
the skeletal muscle cells via three serial steps: delivery of glucose from the blood to the 
sarcolemma, transport across the sarcolemmal membrane by GLUT; and intracellular 
phosphorylation to yield glucose6-phosphate, effectively trapping the glucose inside the 
muscle cell. 
Resistance exercise training: generally encompasses short-duration activity at high or 
maximal exercise intensity, and increases the capacity to perform a single or relatively few 
repetitions of high-intensity exercise. 
NAD
+
-dependent deacetylase silent mating-type information regulator2 homolog 1 
(SIRT1):: an enzyme that deacetylates proteins that contribute tocellular regulation. SIRT1 
acts as fuel sensor and plays a key role in theregulation of cellular stress responses.. 
Skeletal muscle: one of three types of muscle characterized by their connection to bone via 
tendons that enable voluntary bodily movements. Skeletal muscle comprises elongated, 
multinucleated cells termed myofibers that comprise organized, repeating cylinders of 
myofibrils. These contain the basic contractile unit, termed the sarcomere, which contains the 
filament, actin, and the motor protein, myosin. Skeletal muscle can be broken down into two 
main subtypes: red, slow, oxidative, type I and white, fast, glycolytic, type II muscles. 
Tre-2/BUB2/cdc 1 domain 1 and 4 (TBC1D) 1/4): members of the Rab GTPase activating 
proteins (Rab-GAP) family of proteins that arephosphorylated by Akt and AMPK in response 
to insulin, muscle contraction and AICAR.  
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Unccoordinated (unc)-51-like kinase 1 (ULK1): a serine/threonineprotein kinase 
andhomolog of yeast Atg1 that plays a key role in the formation of the pre-autophagosome 
structures during autophagy induction. 
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Phenotypic plasticity of skeletal muscle 
• Skeletal muscle adaptation to the functional demands of exercise 
 Skeletal muscle(see glossary) is a dynamic tissue with considerable plasticity. This is 
well illustrated by the adaptive changes occurringin response to various external stimuli 
(contractile activity, loading conditions, substrate supply, hormonal profile,and environmental 
factors) to match structural, functional, and metabolic demands[1].It is well established that 
physical exercise is a potent stimulus for the adaptation processes,and is known to remodel 
skeletal muscle to better respond to future challenges[2, 3]. Skeletal muscle is able to rapidly 
adapt to exercise interventions, and demonstrates remarkable malleability by changing its 
metabolic and contractile properties. Resistance exercise stimulates muscle protein synthesis 
and leads to growth of muscle fibers and hypertrophy. Bycontrast, endurance exercise leads to 
qualitative changes of muscle tissue by promoting phenotypic adaptations characterized 
mainly by fiber type transformation and increases in structures supporting oxygen delivery 
and consumption (mitochondrial biogenesis and angiogenesis),but no growth. Type IIb and 
type IIx fibers depend mainly on glycolytic pathways for ATP production, whereas type IIa 
and type I fibers rely predominantly on oxidative pathways. 
 
• Regulation of skeletal muscle energy balance during exercise 
 Skeletal muscle contraction is associated with a dramatic increase in energy turnover 
and introduces a major energetic challenge to the muscle fiber. Change in the energy charge 
of the skeletal muscle leads to the activation of the AMP-dependent protein kinase (AMPK). 
This serine/threonine kinase, evolutionarily conserved in all eukaryotes, acts as an 
intracellular fuel sensor sensitive to the relative changes in the cellular AMP:ATPratio and, to 
a lesser extent ADP:ATP ratio, which together signal a fall in cellular energy status[4]. 
AMPK functions as a signaling hub,coordinating anabolic and catabolic pathways to balance 
 7 
nutrient supply with energy demand at both the cellular and whole-body levels. Exercise and 
skeletal muscle contractionare powerful physiological activators of AMPK as 
reportedthoroughly in exercising human skeletal muscle and in isolated contracting rodent 
skeletal muscle[5]. Exercise-induced AMPK activation has been shown to have regulatory 
effects on selected skeletal muscle processes, such as glucose uptake, fatty acid oxidation, 
glycogen metabolism, and protein synthesis as well as mitochondrial biogenesisto promote an 
oxidative muscle phenotype[6, 7]. The action of AMPK is achieved through acute 
phosphorylation of key regulatory proteins in carbohydrate, lipid, and protein metabolism for 
short-term effects, as well as phosphorylation of transcription factors and co-activators for 
longer-term regulatory effects [7, 8]. 
 
 
AMPK: a safeguard of skeletal muscle energy metabolism 
• AMPK structure and activation mechanism 
 AMPK exists as a heterotrimeric complex comprising a catalytic subunit , a 
scaffolding  subunit, and a regulatory  subunit (Figure 1). In mammals, each of the 
subunits occurs as multiple isoforms (1, 2, 1, 2, 1, 2, and 3), encoded by separate 
genes,enabling the formation of a diverse collection of  heterotrimer combinations. The 
mechanism of AMPK activation involves two steps:a reversible phosphorylation at a 
conserved residue (Thr172 in rat 1/2) in the  subunit, and a stimulatory allosteric binding 
of AMP within the C-terminal region of the subunit.The  subunit contains a central 
carbohydrate-binding module that causes AMPK to associate with glycogen particles and has 
inhibitory effects on AMPK activity [9] that prominently operate through 2-containing 
complexes[10]. In skeletal muscle, the major upstream kinase phosphorylating  subunit 
Thr172 is liver kinase B1 (LKB1), as exercise-induced AMPK phosphorylation is prevented 
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in mouse models lacking LKB1[11, 12]. LKB1 is constitutively active, providing a 
continuous basal level of AMPK phosphorylation. AMPK activation is further enhanced by 
conformational changes imposed by binding of AMP and/or ADP to the  subunit,which 
promotes phosphorylation of Thr172and providesprotection against dephosphorylationby 
protein phosphatases[13, 14](Figure 2). Of note, the nature of the  subunit may determine 
the degree of allosteric activation, as 2 complexes have greater AMP sensitivity than 1 
subunits,whichhave greater AMP sensitivity than 3 subunits [15]. The combined effect of 
phosphorylation on Thr172 and allosteric regulation causes a >1000-fold increase in kinase 
activity, allowing high sensitivity in responses to small changes in cellular energy status [16]. 
The Ca
2+
/calmodulin-dependent protein kinase kinase  (CaMKK) has also been shown to 
phosphorylate and activate AMPK in response to an increase in intracellular Ca
2+
 
concentration, independent of any change in cellular AMP:ATP or ADP:ATP ratios[17, 18]. 
CaMKKhas been shown to activate AMPK during mildtetanic skeletal muscle 
contraction[19]and increase AMPK1 activity in response to skeletal muscle overload in 
LKB1-deficient mice [20]. 
 
• AMPK expression profile and regulation of activity 
 In human skeletal muscle, only three complexes have been detected: 221 (65% of 
the total pool), 223 (20%),and 121 (15%) [21](Figure 3). The heterotrimer 
combination varies in mouse skeletal muscle, with the detection of five complexes, including 
1 and 2-associated AMPK complexes with both 1 and 2 isoforms [22](Figure 3). It also 
appears that the expression pattern of AMPK isoforms varies between muscles types 
[22](Figure 3). Of interest, the 3 isoform seems to be exclusively expressed in the fast-
twitch glycolytic extensor digitorum longus (EDL) mouse muscle and not in the slow-twitch 
oxidative soleus mouse muscle [23]. Interestingly, a mutation (R225W) occurring in the gene 
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encoding for the AMPK3 subunitPRKAG3has been reported in pigs[24] and humans[25], 
causing increased deposition of glycogen in skeletal muscle. Recent studies have also 
revealed that each heterotrimer combination displays a distinct activation profile in response 
to physical exercise in human skeletal muscle,with 3-containing complexes (223 
heterotrimer comprising 20% of total AMPK pool) predominantly activated [21], and 221 
and 121 heterotrimers(comprising 80% of total AMPK pool) unchanged or activated only 
after prolonged exercise [26].In addition, the specificity of 2-containing complexes to 
translocate to the nucleus in response to muscle contraction expand the consequences of 
AMPK activation on the transcriptional programs in exercised skeletal muscle[27]. Of 
note,1-containing complexes are usually slightly activated during exercise compared 
with2-containing complexes.An additional layer of complexity emerged from recent 
studiesshowing differential function of specific AMPK heterotrimers, as evidenced by a 
distinct phosphorylation signature in exercised human muscle [28]. Compartmentalization of 
AMPK complexes within the myofiber may provide cluesfor heterotrimer substrate selection 
and particular functional roles. Heterotrimer subcellular localization has been shown to be 
dependent on both myristoylation and phosphorylation of the subunit [29] and the -
associated isoforms in the heterotrimer complex [30]. 
 
• AMPK in the control of exercise-induced metabolic optimization 
 The conversion of skeletal muscle fibers from the more glycolytic fiber (type IIb) to the 
more oxidative fibers (types IIa, IIx and I) iscritical to optimize and enhance energy 
production during endurance exercise. This is consistent with the increase in the ratio of type 
IIa/x fibers in skeletal muscle from mice expressing an AMPK1 gain-of-function mutant 
(R70Q) [31] and from ratschronically treated with the AMP mimetic agent and AMPK 
activator 5-aminoimidazole-4-carboxamide-1--D-ribofuranoside (AICAR)[32]. In addition, 
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using a transgenic mouse model with chronic inhibition of AMPK2 activity, Rockl et al. 
demonstrated that AMPK activationparticipates inthe fiber type IIb to IIa/x transition during 
physical exercise training[31]. Interestingly, activation of AMPK has been recently involved 
in the control of fiber type specification by folliculin-interacting protein 1 (FNIP1)[33]. Loss 
of FNIP1 increases AMPK activation in skeletal muscle and results in a shift in muscle fibers 
from type IIb glycolytic fibers to type I and type IIa oxidative fibers, in a peroxisome 
proliferator-activated receptor  co-activator-1 (PGC-1)-dependent manner. Clearly, the 
negative interaction between FNIP1 and AMPK is an important area for future research, 
particularly in understanding the regulation of metabolic adaptation in skeletal muscle. 
Nevertheless, the role of AMPK in mediating glycolytic-to-oxidative fiber type 
transformation remains ambiguous, as AMPK3 gain-of-function (R225Q) mice[34] and 
AMPK12-deficient mice display normal fiber distribution [35],whereasa compensatory 
increase in the percentage of type I fibershas beenreported in muscle AMPK12-deficient 
mice[36]at rest.Future investigations are needed to confirm the role of AMPK in fiber type 
specification by monitoring fiber type adaptation in AMPK12- and AMPK12-deficient 
mice following exercise training. 
 
• AMPK in the control of fatty acid oxidation 
A major catabolic pathway activated during exercise is fatty acid oxidation. Data 
from experiments using mouse models have provided compelling evidence forthe 
important role of AMPK in regulating fatty acid metabolism in skeletal muscle.It has been 
shown that contraction-induced and pharmacological activation of AMPK stimulates fatty 
acid oxidation in skeletal muscle[37-40]. Thiswas further supported by the increase in fatty 
acid oxidation in skeletal muscle from transgenic mice expressing a AMPK3 gain-of-
function (R225Q) mutant [23]. It was also recently established that AMPK stimulates fatty 
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acid oxidation in skeletal muscle through thephosphorylation and reduction of the activity of 
acetyl-coenzyme A (CoA) carboxylase 2 (ACC2), the enzyme that catalyzes the carboxylation 
of acetyl-CoA to malonyl-CoA,a metabolic intermediate involved in theregulation offatty acid 
oxidation[41]. However, controversies exist about the role of AMPK in regulating fatty acid 
oxidation in skeletal muscle due to the dissociation between AMPK activation, ACC 
phosphorylation, and malonyl-CoA levels during prolonged exercise in humans [42], 
indicating that muscle lipid oxidation isnot completely dependent on the AMPK/ACC 
pathway. Similarly, studies from transgenic mouse models with altered AMPK activity in 
skeletal muscleled to the conclusions that AMPK is not involved in the regulation offatty acid 
oxidation during exercise [43-45], but the presence of residual ACC phosphorylation in the 
muscle of these animals may contribute to the normal metabolic adaptation to contraction and 
the contribution ofthe AMPK/ ACC pathway cannot be definitively excluded. Thus, further 
studies involving the use of knockout mouse models are warranted in order to fully 
understand the contribution of muscle AMPK in the induction of fatty acid oxidation during 
exercise. 
Another mechanism to enhance fatty acid utilization involves the translocation of 
the fatty acid transporter cluster of differentiation 36 (CD36)to the plasma membrane, to 
regulate fatty acid import into muscle cells. Although previous studies indicated that AMPK 
was not essential in the regulation of CD36 translocation and fatty acid uptake during 
contraction[35, 46], recent genetic evidence demonstrated that muscle AMPK12-deficient 
mice have impaired fatty acid utilization during in vivo exercise[47].Absence of exercise-
induced S237 phosphorylation of the Rab GTPase activating proteinTre-2/BUB2/cdc 1 
domain (TBC1D) 1 in AMPK12-deficient muscle may provide a molecular mechanism 
explaining the defect in CD36 translocation and altered fatty acid uptake in response to 
contraction[47] (Figure 4). 
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• AMPK in the regulation of exercise-induced glucose transport 
 During exercise, contracting skeletal muscle rapidly increases glucose uptake in an 
intensity-dependent manner, to sustain the energy demand caused by increased ATP turnover. 
This increase in skeletal muscle glucose uptake is driven by increased capillary recruitment as 
well as translocation of glucose transporter type 4 (GLUT4) to the plasma membrane (Figure 
4). This latter event is required for increased glucose uptake during exercise, in both humans 
and rodents. The mechanisms underlying contraction-induced stimulation of glucose uptake 
have garnered considerable interest, as skeletal muscle contraction is a more potent stimulus 
of skeletal muscle glucose uptake than maximal insulin, and the proximal molecular 
mechanisms regulating insulin and contraction-stimulated glucose transport are distinct 
[48].However, recent findings have shown a convergence of these signals at TBC1D1 and 
TBC1D4,which are emerging as essential players in bothinsulin- and contraction-stimulated 
glucose uptake in skeletal muscle[49-51].It is also important to note that, unlike insulin-
dependent glucose uptake, AMPK-mediated glucose uptake is not impaired in type 2 diabetes 
during exercise[52] and therefore activation of AMPK represents an attractive target for 
intervention.Consistent with this notion, therapeutic doses of metformin increased AMPK 
activity in the skeletal muscle of type 2 diabetics, along with higher rates of glucose disposal 
[53]. 
 In recent years, the importance of AMPK in skeletal muscle glucose uptake has been 
examined extensively in genetically modified mouse models. Studies using the AMPK 
activatorsAICAR[22, 37, 54, 55]and ex229,a cyclic benzimidazole derivative and potent 
direct AMPK activator [56], have shown that pharmacological activation of AMPK is 
sufficient to cause an increase in glucose transport in resting rodent muscle. Intriguingly, 
although AMPK activation by the direct AMPK activator A-769662 is associated with 
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increased glucose uptake in isolated mouse muscle,its action appears to be mediated through a 
phosphoinositide 3-kinase (PI3K)-dependent pathway, indicating potential off-target 
effects[22]. There is genetic evidence to support an important role for AMPK in regulating 
TBC1D1 and TBC1D4 phosphorylation in response to exercise[35, 57, 58]. Consistent with 
these results, AICAR-mediated glucose uptake is blunted in skeletal muscle from TBC1D1- 
and TBC1D4-deficient mice[49-51].Interestingly, in exercised human skeletal muscle, 
TBC1D4 phosphorylation is significantly correlated with an increase in 221 heterotrimer 
activation, whereas TBC1D1 phosphorylation is correlated with the activity of the223 
heterotrimer[28].However, it remains unclear whether AMPK is necessary for contraction-
stimulated glucose transport, as various transgenic AMPK-deficient mouse models display 
decreased, normal, or increased glucose transport, depending on the study [35, 36]. Muscle-
specific knockout of both -AMPK subunits inhibited contraction-stimulated glucose uptake 
[35], while muscle-specific AMPK- deficient mice showed reduced contraction-stimulated 
glucose uptake in soleus but not EDL muscle [36]. These conflicting results could be due to 
redundancy of signaling or diversity in contraction protocols and genetic models, but also 
highlight the extremely complex regulation of contraction-induced glucose uptake. It seems 
unwise to expect a single pathway to account for the full control of contraction-induced 
muscle glucose uptake.Muscle contraction is a multifactorial process and potential signals 
include changes in cellular energy status, reduced creatine phosphate and glycogen 
levels,increases in sarcoplasmic Ca
2+
 levels,generation of reactive oxygen species, and altered 
redox state. Based on the finding that specific Ca
2+
-activated proteins are necessary for the 
translocation of vesicles to the plasma membrane, a direct stimulatory effect of Ca
2+
 release 
from the sarcoplasmic reticulum during contraction is believed to act as a direct feedforward 
mechanism to facilitate GLUT4-mediated glucose transport independently of AMPK 
activation [59].However, Jensen et al. have recently reported the contrastingfinding, that both 
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AMPK and mechanical stress are required for increased glucose transport in skeletal muscle, 
and are sufficient to recruit the full contraction-sensitive glucose transport response, while 
sarcoplasmic Ca
2+
 release is neither sufficient nor required, challenging the working model 
whereby skeletal muscle glucose transport is directly stimulated by Ca
2+
 released from the 
sarcoplasmic reticulum [60]. 
 
• AMPK-dependent long-term control of exercise-induced metabolic adaptations 
 AMPK has emerged as a key mediator of the long-term adaptation to training,with the 
ability to regulate the transcription ofthe glucose transporter GLUT4 and genes involved in 
mitochondrial biogenesis[61](Figure 4). Enhanced GLUT4 gene expression is dependent 
onan AMPK-dependent phosphorylation of the transcriptional repressor histone deacetylase 5 
(HDAC5)following exercise [8]. The transcriptional control of mitochondrial biogenesis is 
mediated through the regulation of PGC-1, a transcriptional co-activator that promotes the 
expression of mitochondrial genes encoded in both nuclear and mitochondrial DNA. 
AMPK activation causes the stimulation of PGC-1 by direct phosphorylation [62]but also 
involves deacetylation through the silent mating-type information regulator 2 homolog 1 
(SIRT1), which is downstream of AMPK,for the triggering of exercise-induced skeletal 
muscle adaptations [63].AMPK also controls the expression of PGC-1by phosphorylating 
HDAC5, leading to the release of myocyte enhancer factor 2 (MEF2) from repression by the 
histone deacetylaseand the activation of PGC-1gene transcription [61, 64]. Interestingly,the 
regulation of HDAC5 phosphorylation can be maintained during exercise despite the absence 
of AMPK by a compensatory activation of protein kinase D (PKD), an alternative HDAC5 
kinase, to control PGC-1gene expression [65]. These results highlight the importance of the 
adaptive response in maintaining the integrity and metabolic capacity of skeletal muscle. In 
the same line, PGC-1-deficient mice remainable to adapt to exercise trainingin a normal 
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fashion, suggesting that other, currently unidentified factors are implicated in exercise-
induced adaptations [66]. 
 The regulation ofPGC-1by AMPKis consistent with the critical role of AMPK in 
initiating mitochondrial biogenesis in response to increases in the intramuscular AMP:ATP 
ratio by the creatine analogue -guanadinipropionic acid (-GPA) [67]. In addition, reduced 
muscle AMPK activity has been associated with decreased mitochondrial content during 
aging [68]and in skeletal muscle from AMPK12- and LKB1-deficient mice [35, 69]. 
However, there are some controversies regarding the role of AMPKin muscle mitochondrial 
biogenesis,as data from AMPK12-deficient mice indicate thatAMPK is dispensable for the 
regulation of baseline mitochondrial muscle content[36]. Nevertheless,loss of AMPK activity 
alters skeletal muscle basal metabolic functionthrough the reduction inthe expression of 
mitochondrial proteins and mitochondrial respiratory capacity[36, 70, 71] and may contribute 
to the exercise intolerance observed in muscle-specific AMPK-deficient mice [35, 36, 72]. 
 
• AMPK in the regulation of skeletal muscle exercise-induced autophagy 
 Recent studies have documented the role of autophagy in the plasticity of skeletal 
muscle in response to exercise [73, 74]. Autophagy is the process by which organelles and 
macromolecular complexes are engulfed into double-membraned vesicles, called 
autophagosomes, and delivered to lysosomes for digestion. During contraction, activation of 
autophagy ensures optimal energy utilization for maintaining cellular energy homeostasis, as 
well as the efficient turnover of damaged organelles following strenuous physical activity. 
AMPK has been shown to play a fundamental role in the stimulation of autophagy in skeletal 
muscle cells by phosphorylating the transcription factor Forkhead box protein O3a (FoxO3a), 
and the autophagy-related protein uncoordinated(unc)-51-like kinase 1 (ULK1), which 
participates in the initiation of autophagosome formation [75]. It has been proposed that 
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autophagy may function in a feed-forward manner to activate AMPK [74], but studies in mice 
deleted of the autophagy-related gene autophagy-related protein 7(atg7) specifically in 
skeletal muscle challenged this hypothesis. Lo Verso et al. showed that inhibition of 
autophagy has no impact on AMPK1 activation and energy provision to fuel contraction[76]. 
However, autophagy appears to be critical for the maintenance of mitochondrial quality 
control during damaging physical activity[76]. 
 
AMPK: a new player in skeletal muscle regeneration 
• AMPK, inflammation, and skeletal muscle regeneration 
Adult skeletal muscle possesses aremarkable capacity to regenerate after injury, 
exercise, or disease. Recent studies revealed that skeletalmuscleregeneration(Box 1) requires 
the migration, proliferation, and fusion of myoblasts to form multinucleated myotubes as well 
as interaction with other cell types within the muscle, including immune cells[77-79]. The 
inflammatory response during skeletal muscle regeneration is a spatially and temporally 
coordinated process. While the first steps of the inflammatory response are associated with 
M1 macrophages, which secrete pro-inflammatory cytokines, resolution of inflammation is 
associated with M2 macrophages, which exhibitan anti-inflammatory phenotype. The 
inflammatory resolution is a critical step and its alteration impairs skeletal muscle 
regeneration. In parallel of its role as an energy sensor, AMPK activation is associated with a 
decrease in the inflammatory response. Onbacterial lipopolysaccharide (LPS) stimulation in 
vitro, while AMPK activation decreases the secretion of pro-inflammatory compounds by 
macrophages, blocking of AMPK action induces an enhanced pro-inflammatory response [80-
82]. In vivo, the administration of AICAR attenuates LPS-induced acute lung injury [82], 
whereas the inhibition of AMPK leads to the opposite effect [83]. 
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Recent evidence demonstrated that macrophage AMPK1 is crucial for the resolution 
of inflammation during skeletal muscle regeneration [84]. Specific deletion of AMPK1in 
macrophages induces a delay in macrophage skewing (M1-to-M2 transition),impairing 
skeletal muscle regeneration. Inversely, rescue experiments with wild type bone marrow 
transplantation in AMPK1-deficient mice improve skeletal muscle regeneration. During the 
regeneration process, AMPK1 activation and macrophage skewing are linked to the 
phagocytosis of apoptotic/necrotic myofibers. In this context, AMPK1 activation in 
macrophagesis dependent on phosphorylation by CaMKKbut not LKB1[84] (Figure 5).  
 
• Energy and muscle stem cell fate choice 
During post-natal skeletal muscle regeneration, muscle stem cells activate and 
recapitulate the myogenic program to repair damaged myofibers. Muscle stem cells are 
capable of both differentiation to repair muscle tissue after injury, and self-renewal to 
replenish the stem cell pool. Control of the return to quiescence is crucial for skeletal muscle 
homeostasis, in order to maintain the pool of satellite cells for future needs. Molecular 
mechanisms that control muscle stem cell self-renewal are starting to be understood and some 
factors involved in this process have now been identified [85, 86]. Interestingly, the AMPK 
upstream kinase LKB1 was shown to limit satellite cell proliferation through the AMPK/ 
mechanistic target of rapamycin complex1 (mTORC1)pathway[87]. In addition, FoxO3, an 
AMPK-regulated transcription factor,has recentlybeen involved in muscle stem cell self-
renewal by pushing cells to quiescence [88].Moreover, it has been established that endothelial 
cells trigger expansion cues to muscle stem cellsthrough the release of vascular endothelial 
growth factor (VEGF), insulin-like growth factor-1 (IGF-1), andfibroblast growth factors 
(FGFs)[89], while perivascular cells promote muscle stem cells self-renewal and quiescence 
through the Angiopoietin-1/Tie-2/extracellular signal-relatedkinase (ERK)1/2 axis [90]. The 
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observation of increased VEGF expression in LKB1-deficient mice[91] reinforces the 
putativelink between theLKB1/ AMPK pathway andthecontrol of muscle stem cell self-
renewal. However, further studies in mice lacking AMPK activity in vascular cells are needed 
to validate this hypothesis. 
It has recently been claimed that regulation of stem cell fate depends on the 
metabolicstate of the cell and the surrounding stem cell niche[92, 93]. Recent work from 
Ryall et al.investigated how metabolic reprogramming promotes the activation of satellite 
cells and modulates myogenic cell fate[94]. Muscle stem cell activation is associated with an 
increase in glycolysis that induces a decrease in intracellular NAD
+
 and a decrease in SIRT1 
expression. This leads to an increase in acetylated H4K16, an epigenetic mark of 
transcriptional activity, and the derepression of several muscle developmental genes. These 
findings reveal a tight link between the metabolic state of satellite cells and epigenetic 
modifications that regulate their myogenic commitment. Thus, manipulating metabolic 
pathways might aid in regulating stem cell fate between self-renewal and differentiation. 
Although the importance of AMPK in stem cells has not yet been extensively studied,it has 
been shown that AMPK activation inhibits mesenchymal stem cells proliferation[95] and 
fosters the differentiation of endothelial cells progenitors[96]. 
Very recently, Rodger etal. highlighted the capacity of quiescentmuscle stem cells to 
enter cell cycle intoa “GAlert” phase (G0-to-G1 pre-transition) [97]. “GAlert” transition of 
quiescent stem cellsallows a rapid response to injury,by priming the cells for cell cycle entry. 
This transition into the alert state is induced bythe activation of mechanistictarget of 
rapamycin complex 1(mTORC1) signaling, and by increases in mitochondrial number and 
function. Because mTORC1 and AMPK are two distinct and opposite signalingpathways[98-
100], the contribution of the opposing functions of mTORC1 and AMPK in this adaptive 
response to skeletal muscle injuryremains to be explored. 
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Skeletal muscle plasticity as a therapeutic target 
•Myokines and whole-body adaptations to exercise 
Muscle contraction has emerged as an important activator of the synthesis and the 
release of severalsecretory cytokines and other peptidemolecules, known as myokines, that 
can exert either autocrine, paracrine, or endocrine effects. These myokines have been 
proposed to mediate whole-body adaptations to exercise through the regulation of skeletal 
muscle metabolism and signaling to distant metabolic organs. The cytokine interleukin-6 (IL)-
6 has been recognized as the prototypicalmyokine, contributing to muscle metabolic 
adaptation and the beneficial systemic effects of exercise training [101]. In the past decade, an 
abundance of evidence has emerged demonstrating that IL-6 stimulates glucose transport and 
fatty acid oxidation in skeletal muscle in an AMPK-dependent fashion [102]. Other myokines, 
such as IL-8 and IL-15, have also been shown more recently to increase glucose transport 
through an increase in AMPK phosphorylation [103]. Similarly, irisin, a newly discovered 
myokine mediating the effects of exercise on adipocyte browning, exerts a direct action 
onskeletal muscle metabolism through AMPK activation[104]. Interestingly, it appears that 
skeletal muscle irisin expression is controlled by an AMPK-PGC-1 signaling cascade, 
suggesting the potential existence of a positive feedback loop [105]. AMPK activation has 
also been proposed to be involved in the mechanism governing IL-6 production and release. 
However, although AMPK was shown to regulate IL-6 release from isolated skeletal muscle 
in response to pharmacological activators of AMPK [106], recent evidence indicates that 
AMPK2 is dispensable for contraction-stimulated IL-6 release [107].  
 
• Engineering skeletal muscle for repair 
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 Degenerating myopathies are characterized by chronic inflammation associated with 
permanent attempts atregeneration and persistent inflammation. Chronic activation of AMPK 
in the dystrophic mdx mouse, a murine model of Duchenne myopathy,with AICAR, improves 
the metabolic function of the skeletal muscle (mainlymitochondrial activity) and leads to an 
improvement of the histological pattern of the muscle by a reduction of both sarcolemma 
damage and regenerating events [108]. Besides the role of AMPK in myofiber and 
mitochondrial metabolism, AMPK also seems to act on the regulation of inflammation in the 
myopathic muscle. Fibrosis andIL-6 and IL-10 levels are reduced in the muscle of AICAR-
treated mdx mice [109]. Therefore, knowledge of the molecular regulation ofthe macrophage 
inflammatory profile may be useful in understanding howthe inflammation balance is 
disrupted in these diseases. In fibrotic mdx muscle, the myeloid population encompasses 
variousmacrophages subsets [110]. The balance between these various populations is 
currently unknown, but analysis of the involvement of AMPK in the balance between the 
macrophage subsets in fibrotic mdx may be relevant to improvingmyopathic muscle. Thus, 
novel knowledge of the mechanisms of skeletal muscle regeneration obtained through satellite 
cells and non-satellite cells holds great therapeutic potential for the treatment of muscle 
disorders. 
 
• Towards exercise mimetics: myth or reality? 
 Physiological adaptations in skeletal muscle are widely recognized to improve whole-
body performance and metabolism in health and disease. Several epidemiological and 
interventional studies have demonstrated that regular physical exercise is of great benefit in 
both the treatment and prevention of clinical conditions including obesity and type 2 diabetes. 
By contrast, physical inactivity is a recognized risk factor for these diseases. Several studies 
have reported an increased proportion of type IIb fibers and decreased numbers of type I 
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fibers with obesity and insulin resistance[111, 112]. However, endurance exercise has been 
reported to cause a switch away from glycolytic type IIb fibers towards more oxidative type I 
and IIa fibers,and is therefore likely to be beneficial[113].In addition, regular moderate-
intensity exercise induces favorable changes in glucose intolerance and decreases mean 
plasma glucose levels in type 2 diabetic patients through increased muscle glucose disposal 
[114]. Thus, beyond human performance, there is great interest in promoting regular exercise, 
combined with an improved diet, not only for protection against the development of obesity 
and type 2 diabetes, but also as a first line of treatment[115]. 
Building on the observation that metabolic reprogramming, which favors oxidative 
over glycolytic metabolism, has a beneficial effect on skeletal muscle, several AMPK 
activators have been proposed as endurance exercise mimetics. For example, resveratrol, a 
natural polyphenolic compound mainly found in red wine and an AMPK activator, increases 
oxidative metabolism and endurance capacity in mice [116]. The effects of resveratrol are 
mediated by AMPK,as skeletal muscle mitochondrial biogenesis and endurance performance 
fail to increase in AMPK-deficient mice [117]. Similarly, AICAR also promotes a high-
endurance phenotype in mice[118]. The question remains as to what extend these data can be 
extrapolated to humans. The first clues will probably come from drug abuse by athletes, as 
AICAR has been recently added to the prohibited list of the World Anti-Doping Agency 
[119]. 
 
Concluding remarks 
Recent major scientific advances have begun to unravel the signaling pathways as well 
as the genetic,biochemical, and metabolic properties ofskeletal muscle through which the 
beneficial effects of physical exercise arise. Studies have highlighted the potential of 
AMPKas an important integrator of cell signaling pathways that mediate the phenotypic 
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plasticity of skeletal muscle, but some specific questions have not been fully explored(Box 2). 
AMPK activation is triggered by sustained contraction, and appears to be particularly 
important in the metabolic changes that occur during physical exercise. Mice lacking AMPK 
or AMPK subunits in skeletal muscle have a dramatically impaired ability to perform 
skeletal muscle contractions and forced treadmill running, and also display reduced voluntary 
wheel running[35, 36]. Exercise-induced AMPK activation acutely activates glucose uptake 
by promoting translocation of the transporter GLUT4 to the membrane. While further studies 
are warranted to fully understand the mechanism by which AMPK promotes GLUT4 
translocation, likely candidates are TBC1D1 and TCB1D4 [28], which have been proposed to 
be the converging point with the insulin signaling pathway and endothelial Nitric Oxide 
Synthase (eNOS), which generates nitric oxide in blood vessels and is involved in regulating 
vascular tone[71]. Understanding how AMPK and other signals are integrated to elicit 
specific changes in glucose transport depending on muscle fiber type and exercise intensity 
remains a challenge that the field still needs to address. Another important metabolic pathway 
targeted by AMPK during contraction is fatty acid oxidation. Recent studies from muscle-
specific AMPK12-deficient micedemonstrated the essential role ofAMPK in enhancing 
fatty acid utilization during exercise. Prolonged AMPK activation also causes some of the 
chronic adaptations to endurance exercise, such as increased GLUT4 expression and 
mitochondrial biogenesis, through the modulation of PGC-1 and SIRT1 activities.Lastly, 
AMPK appears to bea crucial contributor to phagocytosis-induced macrophage skewing 
during the regeneration of damaged skeletal muscle. 
Given the various degrees of beneficial phenotypic plasticity demonstrated by chronic AMPK 
stimulation in pre-clinical animal models, the potential of pharmacological activation of 
AMPK in humans represents a significant challenge. A better understanding of the molecular 
mechanisms involved in the control of skeletal muscle plasticity is important for the opening 
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of new avenues for pharmacological targets in type 2 diabetes and obesity as well as in 
muscle disorders such as muscular dystrophy. Interestingly, changes in the AMPK 
heterotrimer composition and AMPK activation are attenuated with age in response to 
endurance-type muscle contraction and may contribute to skeletal muscle metabolic 
dysfunction in aged sarcopenic muscle [68, 120]. However, reductions in skeletal muscle 
AMPK activity are not sufficient to promote the development of aging-induced insulin-
resistance [121],indicating that AMPK activation may lead to improved strategies for 
preventingthe reduced mitochondrial function and dysregulated intracellular lipid metabolism 
in skeletal muscle associated with aging. 
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Box 1: Skeletal muscle regeneration 
Skeletal muscle regeneration relies on resident adult stem cells, named satellite 
cells,thatundertake a series of cell-fate decisions to ensure efficient repair of the damaged 
muscle fibers. Briefly, these cells remain quiescent under the basal lamina of myofibers and 
are activated after injury. Once activated, these precursor muscle cells proliferate, 
differentiate and fuse to reform new myofibers. A small subset of these precursor muscle cells 
do not differentiate, and return into quiescence to reform a sufficient pool of muscle stem 
cells for further needs [86]. However, to be complete, skeletal muscle regeneration also needs 
the involvement of other cells such as perivascular cells and immune cells like 
macrophages[79].After injury, circulating monocytes enter into the damaged muscle and 
differentiate into pro-inflammatory (M1) macrophages. These M1 macrophages secrete pro-
inflammatory cytokines, phagocytose debris/necrotic myofibers, and activate muscle 
precursor cell proliferation. These macrophages then skew their phenotype and became anti-
inflammatory (M2) macrophages[77]. At this time, M2 macrophages secrete anti-
inflammatory cytokines and sustain myogenesis; that is, the differentiation and fusion of 
muscle precursor cells[77]. 
 
Box 2: Outstanding questions 
• What is the role of AMPK and its variouscomplexes in mediating glycolytic-to-oxidative 
fiber-type transformation?  
• What is the specific mechanism by which AMPK promotes GLUT4 translocation during 
exercise? 
• Does AMPK regulate muscle stem cell-fate choice by way of a “metabolic switch”? 
• How is AMPK involved in the balance between different types of macrophages in 
dystrophic muscle? 
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Figure legends 
Figure 1:Schematic representation of AMP-activated protein kinase(AMPK)subunit 
isoforms. 
AMPK is a heterotrimeric complex comprising a catalytic subunit () and two regulatory 
subunits ( and ), existing as multiple isoforms (1, 2, 1, 2, 1, 2, and 3). AMPK 
contains a kinase domain phosphorylated by upstream kinases on the residue Thr172, an 
autoinhibition domain (AID), and a domain that interacts with the  subunits [ subunit 
interacting domain(-ID)]. AMPK subunit presents domains that interact with glycogen 
[carbohydrate-binding module(CBM)] and the  and  subunits [subunits interacting 
domain(-ID)]. AMPK contains cystathionine -synthase (CBS) domains binding AMP, 
ADP, and ATP, but only three of the four potential nucleotide-binding sites contribute to 
nucleotide regulation, with CBS-2 always unoccupied, CBS-4 permanently bound toAMP and 
CBS-1 and -3 binding AMP, ADP, and ATP interchangeably. 
 
Figure 2: Regulation of AMP-activated protein kinase (AMPK)by exercise. 
Following skeletal muscle contraction, AMP and ADP cellular concentrations and Ca
2+
 levels 
increase. Binding of ADP and AMP to the subunit of AMPK triggers Thr172 
phosphorylation by the upstream kinase liver kinase B1 (LKB1) protects against 
dephosphorylation, maintaining the kinase in an active conformation. After exercise, AMPK 
is returned to an inactive form by dephosphorylation catalyzed by the action of protein 
phosphatases (PP) 1A, 2A, and2C). 
 
Figure 3:AMP-activated protein kinase (AMPK) heterotrimer composition in skeletal 
muscle. 
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A cartoon of the predominant AMPK heterotrimers in human (quadriceps), murine glycolytic 
(EDL, extensor digitorum longus) and oxidative (soleus) muscles is shown. 
 
Figure 4:Schematic overview of AMPK targets in the regulation of skeletal muscle 
adaptation to exercise 
Following exercise, AMPK is activated by low energy status and regulates glucose uptake 
(TBC1D1/ TBC1D4), fatty acid uptake (TBC1D1), fatty acid oxidation (ACC2), 
mitochondrial biogenesis (PGC-1), mitophagy (ULK1), and gene transcription (HDAC5, 
PGC-1, FoxO3).  
Key to abbreviations: ACC, acetyl CoA carboxylase; FoxO3, Forkhead box protein 3; 
HDAC5, histone deacetylase 5; PGC-1, peroxisome proliferator-activated receptor gamma 
coactivator-1; SIRT1, silent mating-type information regulator 2 homolog 1; TBC1D1/4, 
Tre-2/BUB2/cdc domain family domain family, member1/4; ULK1, uncoordinated-51-like 
kinase 1. 
 
Figure 5: Roles of AMPK in skeletal muscle regeneration. 
After an injury of skeletal muscle by cardiotoxin injection, muscle stem cells activate, 
proliferate and enter into the terminal differentiation program to fuse and to form new 
myofibers. A small subset of muscle cells do not differentiate but return to quiescence to 
reform a pool of muscle stem cells (i.e. self-renewal). AMPK implication in these steps 
remains unknown. In parallel, monocyte/macrophages infiltrate the place of injury, acquire 
pro-inflammatory (M1) phenotype and promote myoblast proliferation. Then, pro-
inflammatory (M1) macrophages skew into anti-inflammatory (M2) macrophages, by an 
activation of the CaMKK/AMPK pathway, linked to the phagocytosis of apoptotic/necrotic 
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myofibers. These anti-inflammatory (M2) macrophages sustain myoblast differentiation and 
fusion [84]. 
Key to abbreviations: CTX: cardiotoxin, Mo : monocytes, MPs : macrophages 
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